Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sotagliflozin in Inadequately Controlled Type 1 Diabetes
NCT01742208Phase 2Completed
- Sponsor
- Lexicon Pharmaceuticals, Inc.
- Start
- Feb 2013
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sotagliflozin in type 1 diabetes mellitus (T1D), sponsored by Lexicon Pharmaceuticals, Inc.. Started Feb 2013; status: completed.
02
Drugs
sotagliflozin
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT01742208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01742208.